4.6 Article

A multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial assessing safety and efficacy of active site inactivated recombinant factor VIIa in subjects with acute lung injury or acute respiratory distress syndrome

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation

Frank Niessen et al.

NATURE (2008)

Article Hematology

Transcriptional program induced by factor VIIa-tissue factor, PAR1 and PAR2 in MDA-MB-231 cells

T. Albrektsen et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)

Review Hematology

The tissue factor-factor VIIa complex: procoagulant activity, regulation, and multitasking

D. M. Monroe et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)

Article Hematology

Emerging insights in tissue factor-dependent signaling events

HH Versteeg et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2006)

Article Hematology

Tissue factor in infection and severe inflammation

M Levi et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2006)

Article Hematology

Pharmacological inhibition of tissue factor

PF Laterre et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2006)

Review Critical Care Medicine

Coagulation in sepsis

A Amaral et al.

INTENSIVE CARE MEDICINE (2004)

Article Medicine, General & Internal

Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis -: A randomized controlled trial

E Abraham et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)

Article Critical Care Medicine

Blockade of tissue factor - Treatment for organ injury in established sepsis

MS Carraway et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)

Article Critical Care Medicine

Coagulation blockade prevents sepsis-induced respiratory and renal failure in baboons

KE Welty-Wolf et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)

Article Medicine, General & Internal

High-dose a randomized antithrombin III in severe sepsis -: A randomized controlled trial

BL Warren et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)

Article Pharmacology & Pharmacy

Pharmacokinetics and safety of FFR-rFVIIa after single doses in healthy subjects

E Erhardtsen et al.

JOURNAL OF CLINICAL PHARMACOLOGY (2001)

Article Medicine, General & Internal

Efficacy and safety of recombinant human activated protein C for severe sepsis.

GR Bernard et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)

Article Cardiac & Cardiovascular Systems

Tissue factor-dependent factor VIIa signaling

LC Petersen et al.

TRENDS IN CARDIOVASCULAR MEDICINE (2000)